Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$1.1B
Avg Funding
$45.6M
Global Reach
6
countries

Top Cities for Biopharma

Gerasdorf Bei Wien
Cambridge
New York
Marlborough
Zürich
Milwaukee

Recently Funded Companies

Export
Gerasdorf Bei Wien, Austria

Fermify - universally accessible sustainable food proteins

$1.7M raised
Jul 2023

Founder Contacts

30,000+ verified contacts

Cambridge, United States

City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.

$99.5M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

New York, United States

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

$50.0M raised
Jun 2023

Founder Contacts

30,000+ verified contacts

Marlborough, United States

Akoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.

$43.5M raised
Jun 2023

Founder Contacts

30,000+ verified contacts

Zürich, Switzerland

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

$4.6M raised
Jun 2022

Founder Contacts

30,000+ verified contacts

New York, United States

Aclid is a biotechnology security and compliance automation platform.

$3.3M raised
Jun 2023

Founder Contacts

30,000+ verified contacts

Milwaukee, United States

Ten Bay Bio is a biotechnology company that offers biological therapies for treatment of complex diseases in immunology.

$500K raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Wilmington, United States

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

$22.3M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Wilmington, United States

Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.

$1.9M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Waltham, United States

Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.

$150.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Aliso Viejo, United States

Mammogen specializes in improving the detection, diagnosis, and treatment of breast cancer, from end-to-never-end.

$30.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Radnor, United States

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

$500.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Vancouver, Canada

ME Therapeutics is a biotechnology company that focuses on discovery & development of myeloid cell targeted immuno oncology drugs.

$361K raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Watertown, United States

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

$10.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Liverpool, United Kingdom

Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific

$3.3M raised
Jun 2024

Founder Contacts

30,000+ verified contacts

Woburn, United States

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

$8.5M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Houston, United States

FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.

$3.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Fort Lee, United States

Nuvectis Pharma is a biopharmaceutical company intended to develop novel targeted therapeutics for the treatment of cancer.

$100.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Manassas, United States

Jeeva optimizes and decentralizes clinical research to make innovation accessible to patients regardless of their location.

$75K raised
Jun 2023

Founder Contacts

30,000+ verified contacts

Basel, Switzerland

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.

Jun 2023

Founder Contacts

30,000+ verified contacts

Oakland, United States

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

$62.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

San Francisco, United States

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

$10.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Hiroshima, Japan

Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.

Jun 2025

Founder Contacts

30,000+ verified contacts

Orange, United States

DIMERx operates as a biopharmaceutical company.

$15.0M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

$20.0M raised
Jun 2024

Founder Contacts

30,000+ verified contacts

Showing 126 to 150 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$45.6M
Total Funding Tracked
$1.1B
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.New York
2 companies$53.3M
2.Wilmington
2 companies$24.2M
3.San Francisco
2 companies$30.0M
4.Gerasdorf Bei Wien
1 companies$1.7M
5.Cambridge
1 companies$99.5M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked